#pulmonary — Public Fediverse posts

Inhibition of the epigenetic co-activators p300/CBP prevents alveolar type 2 (AT2) cells from becoming trapped in a pathogenic "alveolar transitional cell state" (ATCS), thereby blocking the progression of idiopathic #pulmonary #fibrosis (#IPF ).
#RegenerativeMedicine #Epigenetics #Genetics #Medical #sflorg
https://www.sflorg.com/2026/02/gen02142601.html

Inhibition of the epigenetic co-activators p300/CBP prevents alveolar type 2 (AT2) cells from becoming trapped in a pathogenic "alveolar transitional cell state" (ATCS), thereby blocking the progression of idiopathic #pulmonary #fibrosis (#IPF ).
#RegenerativeMedicine #Epigenetics #Genetics #Medical #sflorg
https://www.sflorg.com/2026/02/gen02142601.html

Inhibition of the epigenetic co-activators p300/CBP prevents alveolar type 2 (AT2) cells from becoming trapped in a pathogenic "alveolar transitional cell state" (ATCS), thereby blocking the progression of idiopathic #pulmonary #fibrosis (#IPF ).
#RegenerativeMedicine #Epigenetics #Genetics #Medical #sflorg
https://www.sflorg.com/2026/02/gen02142601.html

Inhibition of the epigenetic co-activators p300/CBP prevents alveolar type 2 (AT2) cells from becoming trapped in a pathogenic "alveolar transitional cell state" (ATCS), thereby blocking the progression of idiopathic #pulmonary #fibrosis (#IPF ).
#RegenerativeMedicine #Epigenetics #Genetics #Medical #sflorg
https://www.sflorg.com/2026/02/gen02142601.html

Inhibition of the epigenetic co-activators p300/CBP prevents alveolar type 2 (AT2) cells from becoming trapped in a pathogenic "alveolar transitional cell state" (ATCS), thereby blocking the progression of idiopathic #pulmonary #fibrosis (#IPF ).
#RegenerativeMedicine #Epigenetics #Genetics #Medical #sflorg
https://www.sflorg.com/2026/02/gen02142601.html

St. Luke’s – Global City launches a dedicated inhaler clinic to enhance pulmonary care

St. Luke’s Medical Center is proud to announce the launch of its Inhaler Clinic Service in Global City, designed to optimize the care of patients with pulmonary disorders such as asthma and chronic obstructive pulmonary disease (COPD).

The clinic aims to address a critical gap in respiratory care, including proper inhaler techniques.

Inhaler therapy remains the cornerstone of treatment for many pulmonary conditions. However, studies show that up to 94 percent of patients do not use their inhalers correctly, leading to poor symptom control, frequent exacerbations, and reduced quality of life.

https://twitter.com/tbcnewsph/status/1963819060485050703

Recognizing this, St. Luke’s has established a first-of-its-kind clinic focused on ensuring patients receive not only the proper medication but also the correct technique and support. It also offers coaching on the use and care of nebulizers.

The Inhaler Clinic has a multidisciplinary core team consisting of pulmonologists and respiratory therapists, and is built around four key goals:

● Assess and teach correct inhaler technique to ensure proper medication delivery and better disease control.

● Monitor adherence and treatment outcomes

Regular follow-ups allow the team to evaluate how well patients are using their prescribed therapies and to adjust management plans based on measurable progress.

● Identify and solve device-related problems

The clinic helps resolve issues such as improper device selection, technique errors, or device mismatch such as elderly patients, patients with arthritis, tremors or weakness, etc., supporting more personalized care.

● Empower patients and caregivers through education

Through structured teaching sessions, the clinic equips patients and families with the knowledge and confidence needed to manage respiratory conditions effectively at home.

By focusing on proper device use, personalized guidance, and continuous monitoring, the Inhaler Clinic aims to deliver tangible improvements that matter most to patients:

● Fewer asthma and COPD attacks

● Better medication absorption

● Reduced emergency room visits and hospitalizations

● Improved overall quality of life

Who should be referred to the Inhaler Clinic

Referral to the Inhaler Clinic is recommended for patients who may benefit from focused inhaler education and monitoring, including:

● Newly diagnosed patients with prescribed inhalers

● Individuals with persistent uncontrolled asthma or COPD

● Patients demonstrating recurrent inhaler errors

● Those on complex inhaler regimens (multiple devices or dosing schedules)

● Patients with device mismatch, such as elderly patients with limited hand coordination

● Patients or families expressing confusion or uncertainty

● Patients discharged with new inhaler prescriptions

As the first dedicated inhaler clinic in the Philippines, St. Luke’s sets a new standard in pulmonary care, offering patients a unique, comprehensive service to help them breathe easier.

For more information on referring patients to the Inhaler Clinic, contact the St. Luke’s Product Information Hub at 0947-9930471 / 0998-5822276 / 0939-9161805 / 0928-5200239.

#BUSINESS #Health #Insurance #latest #LIFESTYLE #lungs #news #Philippines #pulmonary #stLukes

New study from #MountSinai, out April 30. Studied ppl w/new heart issues who had mild or asymptomatic cases of COVID; biggest Long-COVID study to date, using heart imaging. Clear connection to several issues, stresses that "infection prevention is crucial".
#MaskUp #mask #respirator #CovidIsNotOver #LongCOVID #long #covid #face #shield #heart #lungs #brain #degraded #scar #tissue #chest #pain #shortness of #breath #fatigue #aorta #valve #disease #pulmonary #hypertension https://www.mountsinai.org/about/newsroom/2025/long-covid-may-cause-long-term-changes-in-the-heart-and-lungs-and-may-lead-to-cardiac-and-pulmonary-diseases

Why don’t we issue refill canisters for inhalers?

We don’t need to replace every mouthpiece every month. Heck.

Wild anti-capitalist radicalism here: MAKE INHALER MOUTHPIECES INTERCHANGEABLE.

Cheaper for manufacturers and wholesalers and patients and our shared biosphere and —.

Ah smoked but Ah did nat inheyl. (“I smoked but I did not inhale.”)

#medicine #sustainable #sustainability #economy #medical #asthma #COPD #respiratory #cardio #pulmonary #inhalation

Improved #pulmonary #function and #exercise #tolerance despite persistent pulmonary #fibrosis over 1 year after severe #COVID19 infection http://thorax.bmj.com/cgi/content/short/79/5/472?rss=1

Despite a high prevalence of fibrotic patterns (64%), pulmonary function, #grip strength, 6 min #walk distance and frailty normalised. Overall, #dyspnoea, #cough and #exhaustion did not improve and were not correlated with pulmonary function or radiographic fibrosis at 15 months, suggesting non-respiratory aetiologies.

Improved #pulmonary #function and #exercise #tolerance despite persistent pulmonary #fibrosis over 1 year after severe #COVID19 infection http://thorax.bmj.com/cgi/content/short/thorax-2023-220370v1?rss=1

Overall, dyspnoea, cough and exhaustion did not improve and were not correlated with pulmonary function or radiographic fibrosis at 15 months, suggesting non-respiratory aetiologies.

DID YOU KNOW?
🔹️25 million people suffer from PH in 🌎?
🔹️3 in 4 pts have advanced dz by the time of dx
🔹️cost of therapies $100k/yr
#phaware #RareDiseaseDay #ShowYourStripes #ShareYourColours
---
RT @PHAssociation
More than 25 million people in the U.S. and 300 million people worldwide are impacted by a rare disease. #Pulmonaryhypertension is often associated with other #rarediseases such as #scleroderma, #HHT, idiopathic #pulmonary…
https://twitter.com/PHAssociation/status/1630572366739718146

Very exicted to share that our #PET #imaging paper in #PulmonaryHypertension #PAH is out: https://doi.org/10.1186/s12931-022-02239-8
Many thanks to our great team at @[email protected] @[email protected]

CONCLUSIONS: Perfusion imaging during O2 + iNO showed a significant difference in the heterogeneity associated with the vertical gradient in perfusion, distinguishing in this small cohort study PAH subjects from controls.

#lung #respiratory #research #pulmonary #perfusion #circulation #PETCT #PIBLabs